Get our introductory offer at only
*$0.99/month for first 3 months
$29.90/month for the next 9 months
BIOSIMILARS maker Samsung Bioepis, part of South Korea's top family-run conglomerate Samsung Group, said on Monday it is seeking regulatory approval in Europe to sell its copy of AbbVie Inc's rheumatoid arthritis drug Humira.
Samsung Bioepis said that the European Medicines